Benzodiazepines Conference (Universidad Miguel Hernández, San Juan de Alicante, Spain)
TrePsy Benzodiazepines Conference was held in Conference Hall, Severo Ochoa Building, Universidad Miguel Hernández, San Juan de Alicante, Alicante, Spain on11th April 2025. The main topic od the Conference is focused on contemporary issues associated with the use of benzodiazepines in therapy, including the possibility of using cannabinoids to alleviate the effects of chronic benzodiazepine use.
Conferences details
Conference Programme
TrePsy Benzodiazepines Conference was held in Conference Hall, Severo Ochoa Building, Universidad Miguel Hernández, San Juan de Alicante, Alicante, Spain on11th April 2025. The main topic od the Conference is focused on contemporary issues associated with the use of benzodiazepines in therapy, including the possibility of using cannabinoids to alleviate the effects of chronic benzodiazepine use.
Opening Ceremony
Opening Ceremony Speakers: Vicente Micol, Vice-Chancellor of International Relations, Universidad Miguel Hernández, Spain; Jan Rodríguez Parkitna, Coordinator TrePsy Project, Deputy Director for Research, Maj Institute of Pharmacology Polish Academy of Sciences, Krakow, Poland; Jorge Manzanares, Coordinator of the Spanish site of TrePsy Project, Full Professor of Pharmacology, Instituto de Neurociencias, Universidad Miguel Hernández, Spain.
Session I: Pharmacology
Speaker 1: Rafael Maldonado, Full Professor of Pharmacology, Department of Medicine and Live Sciences, Neuropharmacology Laboratory Research Group, Universidad Pompeu Fabra, Barcelona, Spain. RIAPAd Benzodiazepines pharmacology. Speaker 2: Jorge Manzanares, Coordinator of the Spanish site of TrePsy Project, Full Professor of Pharmacology, Instituto de Neurociencias, Universidad Miguel Hernández, Spain. RIAPAd Clinical uses of benzodiazepines.
Session II: Epidemiology of benzodiazepine misuse
Speaker 1: Joan Villalbí, Delegate of the Spanish National Plan on Drugs, Spanish Ministry of Health, Spain. The problem of benzodiazepines in Spain. Speaker 2: Jose Augusto Pochapski, Central Intitute of Mental Health, Mannheim Prevalence and harms of benzodiazepines in Europe.
Session III: Molecular targets of benzodiazepines
Speaker 1: María Salud García Gutiérrez, Associate Professor of Pharmacology, Instituto de Neurociencias, Universidad Miguel Hernández, Spain. RIAPAd GABAA receptor subtypes in the regulation of pharmacological actions of benzodiazepines. Speaker 2: Jorge Manzanares, Coordinator of the Spanish site of TrePsy Project, Full Professor of Pharmacology, Instituto de Neurociencias, Universidad Miguel Hernández, Spain. RIAPAd Cannabinoid mediated regulation of benzodiazepines.
Session IV: Clinical management of benzodiazepines use disorder
Speaker 1: Sonia Álvarez Sesmero, Psychiatrist, Hospital 12 de Octubre, Madrid, Spain. How to aboid abuse or dependence of benzodiazepines Speaker 2: Marta Marín Mayor, Psychiatrist, Hospital 12 de Octubre, Madrid, Spain. RIAPAd Treatment of benzodiazepines dependence.
Session V: New targets or drugs to treat benzodiazepines use disorder
Speaker 1: Gonzalo Herradón Gil-Gallardo, Full Professor of Pharmacology, Universidad San Pablo CEU, Madrid, Spain. RIAPAd Orexines and more. Speaker 2: Francisco Navarrete Rueda, Associate Professor of Pharmacology, Instituto de Neurociencias, Universidad Miguel Hernández, Spain. RIAPAd CBD-mediated regulation of benzodiazepines withdrawal.
Concluding Remarks
Concluding Remarks of the TrePsy Benzodiazepines Conference